| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,125 |
15,580 |
$1.04M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,794 |
4,762 |
$122K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
548 |
532 |
$54K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
137 |
135 |
$20K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
157 |
157 |
$15K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
100 |
100 |
$10K |
| 99051 |
|
479 |
475 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
36 |
36 |
$4K |
| 0071A |
|
97 |
97 |
$3K |
| 0072A |
|
73 |
73 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
90 |
89 |
$3K |
| 99173 |
|
1,163 |
1,163 |
$2K |
| 96127 |
|
171 |
170 |
$1K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
66 |
54 |
$907.20 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$667.03 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27 |
19 |
$516.58 |
| H0049 |
Alcohol and/or drug screening |
13 |
13 |
$429.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
12 |
12 |
$187.20 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$169.87 |
| 96160 |
|
67 |
67 |
$164.21 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$150.53 |
| 92551 |
|
13 |
13 |
$118.15 |
| 90686 |
|
12 |
12 |
$0.00 |